Search research articles
Contact Us
Filters
Showing results (661-670 of 673) with videos related to
Page
of 68
Sort By:
Angewandte Chemie (International Ed. in English)
|
September 16, 2014
Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems
Xiaoxuan Liu, Jiehua Zhou, Tianzhu Yu, et al.
National Science Review
|
March 11, 2025
A smart millimeter-wave base station for 6G application based on programmable metasurface
Jun Wei Zhang, Zhen Jie Qi, Li Jie Wu, et al.
Frontiers in Immunology
|
March 6, 2023
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, et al.
World Journal of Pediatrics : WJP
|
January 18, 2024
Brain development in newborns and infants after ECMO
Kai Yan, Lu-Kun Tang, Fei-Fan Xiao, et al.
World Journal of Pediatrics : WJP
|
June 15, 2023
Risk stratification of hemodynamically significant patent ductus arteriosus by clinical and genetic factors
Yu-Xi Chen, Tian-Tian Xiao, Hui-Yao Chen, et al.
Light, Science & Applications
|
October 25, 2022
Challenges and strategies in high-accuracy manufacturing of the world's largest SiC aspheric mirror
Xuejun Zhang, Haixiang Hu, Xiaokun Wang, et al.
Nature Communications
|
December 4, 2015
Target engagement and drug residence time can be observed in living cells with BRET
Matthew B Robers, Melanie L Dart, Carolyn C Woodroofe, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Novel Hybrid Peptide Cathelicidin 2 (1-13)-Thymopentin (TP5) and Its Derived Peptides with Effective Antibacterial, Antibiofilm, and Anti-Adhesion Activities
He-Nan Guo, Yu-Cui Tong, Hui-Li Wang, et al.
Oncotarget
|
November 5, 2017
Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells
Li-Li Ma, Lan Shen, Gui-Hui Tong, et al.
Nature Medicine
|
January 19, 2024
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 673) with videos related to
Sort By:
Page
of 68
Angewandte Chemie (International Ed. in English)
|
September 16, 2014
Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems
Xiaoxuan Liu, Jiehua Zhou, Tianzhu Yu, et al.
National Science Review
|
March 11, 2025
A smart millimeter-wave base station for 6G application based on programmable metasurface
Jun Wei Zhang, Zhen Jie Qi, Li Jie Wu, et al.
Frontiers in Immunology
|
March 6, 2023
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, et al.
World Journal of Pediatrics : WJP
|
January 18, 2024
Brain development in newborns and infants after ECMO
Kai Yan, Lu-Kun Tang, Fei-Fan Xiao, et al.
World Journal of Pediatrics : WJP
|
June 15, 2023
Risk stratification of hemodynamically significant patent ductus arteriosus by clinical and genetic factors
Yu-Xi Chen, Tian-Tian Xiao, Hui-Yao Chen, et al.
Light, Science & Applications
|
October 25, 2022
Challenges and strategies in high-accuracy manufacturing of the world's largest SiC aspheric mirror
Xuejun Zhang, Haixiang Hu, Xiaokun Wang, et al.
Nature Communications
|
December 4, 2015
Target engagement and drug residence time can be observed in living cells with BRET
Matthew B Robers, Melanie L Dart, Carolyn C Woodroofe, et al.
International Journal of Molecular Sciences
|
November 13, 2021
Novel Hybrid Peptide Cathelicidin 2 (1-13)-Thymopentin (TP5) and Its Derived Peptides with Effective Antibacterial, Antibiofilm, and Anti-Adhesion Activities
He-Nan Guo, Yu-Cui Tong, Hui-Li Wang, et al.
Oncotarget
|
November 5, 2017
Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells
Li-Li Ma, Lan Shen, Gui-Hui Tong, et al.
Nature Medicine
|
January 19, 2024
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, et al.
Page
of 68